NCT01039233View on ClinicalTrials.gov

Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex 50 mg Tablet in Healthy Subjects Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

June 30, 2005

Study Completion Date

July 31, 2005

Conditions
Bioequivalency
Interventions
DRUG

Bicalutamide 50 mg Tablet vs Casodex® 50 mg Tablet

Trial Locations (1)

H3X 2H9

SFBC Anapharm, Montreal

Sponsors
All Listed Sponsors
collaborator

Watson Laboratories, Inc.

INDUSTRY

lead

Kremers Urban Development Company

INDUSTRY

NCT01039233 - Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex 50 mg Tablet in Healthy Subjects Under Fasting Conditions | Biotech Hunter | Biotech Hunter